Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Case Comprehensive Cancer Center
University College, London
Masonic Cancer Center, University of Minnesota
Yale University
Cellerant Therapeutics
Duke University
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Alaunos Therapeutics
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey